Display Settings:

Format

Send to:

Choose Destination
    Trends Pharmacol Sci. 1990 Mar;11(3):122-6.

    Somnogenic activity of immune response modifiers.

    Source

    Department of Physiology and Biophysics, College of Medicine, University of Tennessee Memphis 38163.

    Abstract

    Sleepiness is a presenting symptom in nearly all infectious diseases. James Krueger describes how microbial products, such as muramyl peptides, lipid A and double-stranded RNA, as well as endogenous products elicited by these substances, such as interleukin 1, modulate sleep. The altered sleep during infection seems to result from an exaggerated activation of physiological sleep mechanisms, since normal sleep is controlled by a wide range of substances including many of these immune response modifiers.

    PMID:
    2104463
    [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Full Text Sources

    Other Literature Sources

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk